Azimuth Capital Investment Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.99M Buy
103,722
+35,920
+53% +$3.44M 0.34% 102
2025
Q4
$6.51M Buy
67,802
+1,318
+2% +$128K 0.23% 129
2025
Q3
$6.33M Sell
66,484
-823
-1% -$75.7K 0.23% 127
2025
Q2
$5.87M Buy
67,307
+425
+0.6% +$36K 0.22% 131
2025
Q1
$6.01M Sell
66,882
-21,038
-24% -$1.88M 0.24% 129
2024
Q4
$7.02M Buy
87,920
+3,250
+4% +$281K 0.27% 118
2024
Q3
$7.62M Buy
84,670
+4,412
+5% +$371K 0.3% 115
2024
Q2
$6.32M Buy
80,258
+1,230
+2% +$101K 0.26% 125
2024
Q1
$6.89M Buy
79,028
+192
+0.2% +$16.4K 0.28% 120
2023
Q4
$6.49M Buy
78,836
+25,159
+47% +$1.92M 0.29% 117
2023
Q3
$4.21M Buy
53,677
+33,647
+168% +$2.82M 0.21% 141
2023
Q2
$1.76M Buy
20,030
+9,265
+86% +$798K 0.08% 194
2023
Q1
$868K Buy
10,765
+6,450
+149% +$526K 0.04% 225
2022
Q4
$335K Sell
4,315
-100
-2% -$8.11K 0.02% 272
2022
Q3
$357K Hold
4,415
0.02% 262
2022
Q2
$396K Buy
+4,415
New +$447K 0.02% 265

Other funds holding MDT

Azimuth Capital Investment Management's MDT Position: Q1 2026 in Review

Azimuth Capital Investment Management increased its Medtronic (MDT) stake by 53% in Q1 2026, buying an estimated $3.44M and bringing the position to 103,722 shares worth $8.99M. The position accounts for 0.34% of the portfolio, ranked #102.

Azimuth Capital Investment Management first reported a position in MDT in Q2 2022 and has held it in 16 quarters since. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Azimuth Capital Investment Management held 103,722 shares of Medtronic worth $8.99M as of Q1 2026.
  • Azimuth Capital Investment Management bought 35,920 Medtronic shares in Q1 2026, an estimated $3.44M.
  • Medtronic made up 0.34% of Azimuth Capital Investment Management's portfolio in Q1 2026, its #102 holding.
  • Azimuth Capital Investment Management first reported a position in Medtronic in Q2 2022 and has held it in 16 quarters since.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Azimuth Capital Investment Management's 13F filing for Q1 2026, filed 12 May 2026.